Commentary:

Krejs GJ . VIPoma syndrome. Am J Med 1987;82: 37.

Oberg K Kvols L Caplin M . Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol 2004;15: 966–73.

Kwekkeboom D Krenning E Klemens S . ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Somatostatin Receptor Imaging with¹¹¹In-Pentetreotide. Neuroendocrinology 2009;90: 184–89.

Florio T . Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors. Front Biosci 2008;13: 822–24.

Al-Zubairy SA Al-Jazairi AS . Octreotide as a therapeutic option for management of chylothorax. Ann Pharmacother 2003;37: 679–83.